Application of EGFR, ki 67 and GFAP as a panel for the diagnosis and grading of astrocytomas

Correlating DNMT1, PCNA, and RB1 genes as new prognostic biomarkers

The prognostic significance of Minichromosome maintenance protein 2 (MCM2) and Trans-glutaminase 2 (TGM2) in Endometrial carcinoma: immunohistochemical and serological study

Molecular insights into the repair mechanism of enzymatic DNA-protein cross-link damage induced by a DNMT inhibitor

Prognostic value of Isocitrate Dehydrogenase And Mismatch Repair Genes In Gliomas

GFBR3 Promoter Methylation Is A Prognostic Indicator And Not Responding To Decitabine Treatment In Hepatocellular Carcinoma

Exploring the diagnostic significance of Astrocyte Elevated Gene 1 (AEG1) and Glypican 3 immunohistochemical expression in differentiating hepatocellular carcinoma and mimickers

Study the effect of FGFR2 and FGFR4 gene variants on the response to cyclophosphamide doxorubicin-docetaxel based chemotherapy in locally advanced breast cancer patients

Promoter methylation of certain tumor regulatory genes and hepatocellular carcinoma

Soluble CD44 is a promising biomarker with a prognostic value in breast cancer patients